Benitec Biopharma Stock Forecast - Jensen Alpha
BNTC Stock | USD 11.74 0.44 3.61% |
Benitec Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Benitec Biopharma stock prices and determine the direction of Benitec Biopharma Ltd's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Benitec Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
Benitec |
Check Benitec Biopharma Volatility | Backtest Benitec Biopharma | Trend Details |
Benitec Biopharma Trading Date Momentum
On December 04 2024 Benitec Biopharma Ltd was traded for 9.85 at the closing time. The top price for the day was 10.10 and the lowest listed price was 9.73 . The trading volume for the day was 50 K. The trading history from December 4, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.50% . The overall trading delta against the current closing price is 13.50% . |
Compare Benitec Biopharma to competition |
Other Forecasting Options for Benitec Biopharma
For every potential investor in Benitec, whether a beginner or expert, Benitec Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Benitec Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Benitec. Basic forecasting techniques help filter out the noise by identifying Benitec Biopharma's price trends.Benitec Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Benitec Biopharma stock to make a market-neutral strategy. Peer analysis of Benitec Biopharma could also be used in its relative valuation, which is a method of valuing Benitec Biopharma by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Benitec Biopharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Benitec Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Benitec Biopharma's current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Benitec Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Benitec Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Benitec Biopharma shares will generate the highest return on investment. By undertsting and applying Benitec Biopharma stock market strength indicators, traders can identify Benitec Biopharma Ltd entry and exit signals to maximize returns.
Benitec Biopharma Risk Indicators
The analysis of Benitec Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Benitec Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting benitec stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 3.63 | |||
Semi Deviation | 3.3 | |||
Standard Deviation | 5.11 | |||
Variance | 26.12 | |||
Downside Variance | 12.42 | |||
Semi Variance | 10.88 | |||
Expected Short fall | (4.82) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Benitec Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Benitec Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Benitec Biopharma Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Benitec Biopharma Ltd Stock:Check out Historical Fundamental Analysis of Benitec Biopharma to cross-verify your projections. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Benitec Biopharma. If investors know Benitec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Benitec Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.51) | Revenue Per Share 0.003 | Quarterly Revenue Growth 0.125 | Return On Assets (0.50) | Return On Equity (0.92) |
The market value of Benitec Biopharma is measured differently than its book value, which is the value of Benitec that is recorded on the company's balance sheet. Investors also form their own opinion of Benitec Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Benitec Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Benitec Biopharma's market value can be influenced by many factors that don't directly affect Benitec Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Benitec Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Benitec Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Benitec Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.